Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Kim Forest Enterprise Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$-26.8 Mil. Kim Forest Enterprise Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-2.4 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Kim Forest Enterprise Co's Interest Coverage or its related term are showing as below:
TPE:6645's Interest Coverage is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 9.155 * Ranked among companies with meaningful Interest Coverage only.
Kim Forest Enterprise Co (TPE:6645) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Kim Forest Enterprise Co Interest Coverage Related Terms
Kim Forest Enterprise Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TPE:6645 vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Kim Forest Enterprise Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kim Forest Enterprise Co Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Kim Forest Enterprise Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Kim Forest Enterprise Co's Interest Coverage falls into.
Kim Forest Enterprise Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Kim Forest Enterprise Co did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Kim Forest Enterprise Co (TPE:6645) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kim Forest Enterprise Co and its competitors. According to the industry distribution chart, Kim Forest Enterprise Co ranks #999999 out of 94 companies in the Medical Diagnostics & Research industry.
Is Kim Forest Enterprise Co's Interest Coverage too high?
Kim Forest Enterprise Co's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Kim Forest Enterprise Co ranks #999999 out of 94 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Kim Forest Enterprise Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kim Forest Enterprise Co's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Kim Forest Enterprise Co ranks #999999 out of 94 companies for Interest Coverage. This places Kim Forest Enterprise Co in the lower half of its industry. The industry median Interest Coverage is 9.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.16, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Kim Forest Enterprise Co and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kim Forest Enterprise Co's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kim Forest Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Kim Forest Enterprise Co (TPE:6645) is currently considered Possible Value Trap. The stock's GF Value™ is NT$24.71, compared to a current price of NT$16.00 — trading 35.2% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Kim Forest Enterprise Co's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Kim Forest Enterprise Co (TPE:6645), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kim Forest Enterprise Co (TPE:6645) Overvalued in 2026?
Based on GuruFocus' analysis, Kim Forest Enterprise Co stock appears to be undervalued.
The current stock price of NT$16.00 is trading 35.2% below its estimated GF Value™ of NT$24.71.
GuruFocus considers Kim Forest Enterprise Co to be Possible Value Trap.
Key valuation signals for TPE:6645:
Interest Coverage: 0 (At Loss)
GF Value™: NT$24.71 vs. price of NT$16.00 (35.2% below fair value)
No single metric tells the full story. See the TPE:6645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kim Forest Enterprise Co Ltd is engaged in providing clinical medical information, genetic testing services, and biological information. It manufactures medical equipment and also produces drug products. The company's equipment includes Desktop microcentrifuge, Desktop large capacity centrifuge, Filter-type absorption spectrometer, Multifunctional spectrometer, and many more. Its reportable segments are Biomedical products which generates key revenue, and the Precision medicine segment. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States of America.
61GF Score
Get the complete analysis for TPE:6645
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6645 has been successfully added to your 
